首页 | 本学科首页   官方微博 | 高级检索  
     


Synthetic lethal interaction of combined CD26 and Bcl‐xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma
Authors:Tsukasa Kawaguchi  Takahiro Kodama  Hayato Hikita  Yuki Makino  Yoshinobu Saito  Satoshi Tanaka  Satoshi Shimizu  Ryotaro Sakamori  Takuya Miyagi  Hiroshi Wada  Hiroaki Nagano  Naoki Hiramatsu  Tomohide Tatsumi  Tetsuo Takehara
Affiliation:1. Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan;2. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
Abstract:
Keywords:ABT‐737  apoptosis  CD26  cell cycle  hepatocellular carcinoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号